Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
Bayer’s elinzanetant meets all primary and key secondary endpoints in OASIS 1 and 2 Phase III studies
AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary endpoint
Global coalition for World Contraception Day encourages young people to make informed contraception decisions
BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
9 - 16of 82 News
9 - 16of 82 News
Contact us:
Communications Department
Email: mediacanada@bayer.com